The two main types, Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), may involve chemotherapy, radiation therapy, ...

Bristol-Myers Squibb has shored up manufacturing of its CAR-T therapies, tapping into capacity at contract manufacturer ...

Steve Hare is well aware that he is in the battle of his life as he wages war for the third time against cancer. The Claridon ...

Combination treatments with two or more blood pressure drugs can significantly reduce blood pressure in patients taking ...

A new research paper was published in Oncotarget entitled, "Novel therapeutic bispecific antibodies for B-cell lymphoma ...

(Nasdaq: GILD) announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of ...

Eli Lilly (LLY) enjoys strong fundamentals and is expected to consistently do well, mainly supported by its new drugs and its ...

Meeting of ASCO is a major event for clinicians and researchers in the field of oncology. Explore more details here.

Facing pressure from the Inflation Reduction Act (IRA) and falling sales for CAR-T therapy Abecma, Bristol Myers Squibb CEO ...

Here are some tips for making daily exercise a little easier: ...

TG Therapeutics has strong barriers to entry and patent protection for BRIUMVI, allowing for potential growth in '24 and '25.

In 2023, DLBCL had the highest number of cases among all selected indications for CAR-T therapy, followed by Follicular ...